Ishita Drugs & Ind Stock: price and insider trades · India
No insider purchase over the last 90 days. The latest, by Ishita Pharmaceuticals, was filed 22 Jul 2026.
Ishita Drugs & Ind: what insiders have been doing
Every trade that managers of Ishita Drugs & Ind disclose to SEBI (PIT + SAST) is tracked on this page. Between 10 November 2025 and 10 November 2026, 1 insider published 2 filings.
Only purchases show up on the open market, 2 purchases in all, filed by 1 insider. The totals do not cover 2 filings with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
Across the 1,984 companies tracked on its exchange, the median is 4 filings; at 2 filings, this issuer sits below that mark. Over the whole record (from 2026), the tally stands at 2 purchases and no sales.
The latest purchase dates back some time: it was published 111 days ago, on 22 July 2026.
These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.
Who traded when
BuySaleTransparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 223 shares-MarketSEBI:1cf1e25412f75e688f902d2afbdc1174aae4c66eCanonical exit: 20 Oct 2026 (T+90)
- 55 shares-MarketSEBI:0b3a186264f1a2660187dc9880b39b2f4af02054Canonical exit: 20 Oct 2026 (T+90)
2 of 2 declarations
About Ishita Drugs & Ind
Ishita Drugs & Ind is a company listed on the Bombay Stock Exchange, specializing in the manufacturing of pharmaceutical products. It focuses on the development and production of generic drugs and formulations.